SCHEMBL6555136

SCHEMBL6555136

CCOc1cc(Cc2cnc(N)nc2N)cc(O)c1-c1ccc(CN2CCOCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557155 0.94 DHFR (0.54) DHFR
SCHEMBL6555063 0.91 DHFR (0.48) DHFR
SCHEMBL6555159 0.89 DHFR (0.47) DHFR
SCHEMBL6555540 0.89 DHFR (0.49) DHFR
SCHEMBL6557288 0.86 DHFR (0.48) DHFR
SCHEMBL6556460 0.85 DHFR (0.54) DHFR
SCHEMBL7572273 0.85 DHFR (0.43) DHFR
SCHEMBL6866050 0.85 DHFR (0.45) DHFR
SCHEMBL6555101 0.84 DHFR (0.52) DHFR
SCHEMBL6555407 0.83 DHFR (0.57) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed